Having book value of 94, available  at 8 PE against  17 Industry PE, and enjoying lower crude oil price, have posted good profit in H1, H2 will be also better than H1. The stock is attractive @ 99-100 price for the medium to long term.
 
|  | 
Sep '15 | 
Mar '15 | 
Sep '14 | 
| 
Net Sales/Income from operations | 
2098.77 | 
2249.02 | 
1757.04 | 
| 
Other Operating Income | 
8.12 | 
8.21 | 
3.55 | 
| 
Total Income From Operations | 
2106.89 | 
2257.23 | 
1760.59 | 
| 
EXPENDITURE |  |  | |
| 
Consumption of Raw Materials | 
1414.48 | 
1456.21 | 
1162.64 | 
| 
Purchase of Traded Goods | 
14.63 | 
-- | 
-- | 
| 
Increase/Decrease in Stocks | 
-9.13 | 
11.26 | 
-7.62 | 
| 
Power & Fuel | 
-- | 
-- | 
-- | 
| 
Employees Cost | 
68.6 | 
71.19 | 
56.49 | 
| 
Depreciation | 
89.99 | 
79.91 | 
64.93 | 
| 
Excise Duty | 
-- | 
-- | 
-- | 
| 
Admin. And Selling Expenses | 
-- | 
-- | 
-- | 
| 
R & D Expenses | 
-- | 
-- | 
-- | 
| 
Provisions And Contingencies | 
-- | 
-- | 
-- | 
| 
Exp. Capitalised | 
-- | 
-- | 
-- | 
| 
Other Expenses | 
196.58 | 
177.84 | 
178.34 | 
| 
P/L Before Other Inc. , Int., Excpt. Items &
  Tax | 
331.75 | 
460.83 | 
305.81 | 
| 
Other Income | 
45.53 | 
73.32 | 
27.11 | 
| 
P/L Before Int., Excpt. Items & Tax | 
377.28 | 
534.15 | 
332.92 | 
| 
Interest | 
112.62 | 
114.23 | 
114.3 | 
| 
P/L Before Exceptional Items & Tax | 
264.66 | 
419.92 | 
218.62 | 
| 
Exceptional Items | 
-5.68 | 
-12.55 | 
-9.24 | 
| 
P/L Before Tax | 
258.98 | 
407.36 | 
209.38 | 
| 
Tax | 
73.6 | 
91.67 | 
67.55 | 
| 
P/L After Tax from Ordinary Activities | 
185.38 | 
315.69 | 
141.83 | 
| 
Prior Year Adjustments | 
-- | 
-- | 
-- | 
| 
Extra Ordinary Items | 
-- | 
-- | 
-- | 
| 
Net Profit/(Loss) For the Period | 
185.38 | 
315.69 | 
141.83 | 
| 
Equity Share Capital | 
44.46 | 
42.44 | 
35.51 | 
| 
Reserves Excluding Revaluation Reserves | 
-- | 
-- | 
-- | 
| 
Equity Dividend Rate (%) | 
-- | 
-- | 
-- | 
| 
EPS Before Extra Ordinary |  |  | |
| 
Basic EPS | 
4.24 | 
-- | 
4.3 | 
| 
Diluted EPS | 
4.2 | 
-- | 
4.14 | 
 
 
Biocon/Mylan launch Semglee in UK.
ReplyDeleteequitytips